LINC01812

Across TCGA pan-cancer cohorts, LINC01812 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LINC01812 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher LINC01812 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01812 expression acts as an unfavorable survival marker, although some lineages such as CESC and OV show a favorable association.

KIRP, UVM, and CESC are the cancer types where LINC01812 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Tertile	III,IV	0.339	0.751	<.001	96	view →
UVM	DFS	Tertile	All	0.337	0.657	<.001	87	view →
CESC	OS	Median	III,IV	0.846	0.506	.002	62	view →
LIHC	OS	Tertile	All	0.417	0.737	<.001	54	view →
HNSC	DFS	Tertile	II,III,IV	0.603	0.720	.006	50	view →
ACC	OS	Tertile	III,IV	0.311	0.789	.002	39	view →
LGG	OS	Tertile	All	0.648	0.862	<.001	39	view →
MESO	OS	Tertile	IV	0.151	0.677	.001	32	view →
STAD	DFS	Median	All	0.340	0.631	.019	25	view →
OV	OS	Tertile	All	0.891	0.787	.002	20	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	15	view →
TGCT	DFS	Median	All	0.900	0.700	.002	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

LINC01812–KIRP (DFS)

Open the KIRP breakdown →